Stany Zjednoczone - angielski - NLM (National Library of Medicine)

a-s medication solutions - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - norethindrone 0.35 mg - progestin-only oral contraceptives are indicated for the prevention of pregnancy. if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. however, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. table 1 lists the pregnancy rates for users of all major methods of contraception.   % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year‡ method (1) typical use§ (2) perfect use¶ (3) (4) chance# 85 85   spermicidesÞ 26 6 40 periodic abstinence 25   63 calendar   9   ovulation method   3   sympto-thermalß   2   post-ovulation   1   capà       parous women 40 26 42 nulliparous women 20 9 56 sponge       parous women 40 20 42 nulliparous women 20 9 56 diaphragmà 20 6 56 withdrawal 19 4   condomè       female (reality®) 21 5 56 male 14 3 61 pill 5   71 progestin only   0.5   combined   0.1   iud       progesterone t 2.0 1.5 81 copper t380a 0.8 0.6 78 lng 20 0.1 0.1 81 depo-provera®

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - norethindrone 0.35 mg - progestin-only oral contraceptives are indicated for the prevention of pregnancy. if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.3%. however, the typical failure rate is estimated to be closer to 9%, due to late or omitted pills. table 1 lists the pregnancy rates for users of all major methods of contraception. errin ® tablets have not been studied for and are not indicated for use in emergency contraception. progestin-only oral contraceptives (pops) should not be used by women who currently have the following conditions: - known or suspected pregnancy - known or suspected carcinoma of the breast - undiagnosed abnormal genital bleeding - hypersensitivity to any component of this product - benign or malignant liver tumors - acute liver disease

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - progestin-only oral contraceptives are indicated for the prevention of pregnancy. if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. however, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. the following table lists the pregnancy rates for users of all major methods of contraception. progestin-only oral contraceptives (pops) should not be used by women who currently have the following conditions: - known or suspected pregnancy - known or suspected carcinoma of the breast - undiagnosed abnormal genital bleeding - hypersensitivity to any component of this product - benign or malignant liver tumors - acute liver disease

Kanada - angielski - Health Canada

aspen pharmacare canada inc. - dienogest - tablet - 2mg - dienogest 2mg - progestins

Kanada - angielski - Health Canada

jamp pharma corporation - dienogest - tablet - 2mg - dienogest 2mg - progestins

Kanada - angielski - Health Canada

knight therapeutics inc. - estradiol (estradiol hemihydrate); progesterone - capsule - 0.5mg; 100mg - estradiol (estradiol hemihydrate) 0.5mg; progesterone 100mg - progestins

Kanada - angielski - Health Canada

knight therapeutics inc. - estradiol (estradiol hemihydrate); progesterone - capsule - 1mg; 100mg - estradiol (estradiol hemihydrate) 1mg; progesterone 100mg - progestins

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

proficient rx lp - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - progestin-only oral contraceptives are indicated for the prevention of pregnancy. if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. however, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. table 1 lists the pregnancy rates for users of all major methods of contraception. chance# 85 85 spermicidesÞ 26 6 40 periodic abstinence 25 63   calendar 9   ovulation method 3   sympto-thermalß 2   post-ovulation 1 capà   parous women 40 26 42   nulliparous women 20 9 56 sponge   parous women 40 20 42   nulliparous women 20 9 56 diaphragmà 20 6 56 withdrawal 19 4 condomè   female (reality) 21 5 56   male 14 3 61 pill 5 71 progestin only 0.5 combined 0.1 iud   progesterone t 2 1.5 81   copper t380a 0.8 0.6 78   lng 20 0.1 0.1 81 depo-provera 0.3 0.3 70 norplant and norplant-2 0.05 0.05 88 female sterilization 0.5 0.5 100 male sterilization 0.15 0.10 100 norethindrone tablets have not been studied for and are not indicated for use in emergency contraception. progestin-only oral contraceptives (pops) should not be used by women who currently have the following conditions:

Kanada - angielski - Health Canada

ibsa institut biochimique sa - progesterone - solution - 25mg - progesterone 25mg - progestins

Izrael - angielski - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 10 mg - cyproterone - cyproterone - treatment of pronounced signs of virilisation in women, which make hormone therapy necessary:• severe forms of acne, when it is accompanied by inflammation and the formation of nodes (acne papulopustulosa, acne nodulocystica) or if there is a risk of scarring,• moderate to severe forms of hirsutism,• moderate to severe forms of androgenic alopecia.cyproterone acetate 10 mg is indicated for pronounced signes of virilisation in women, which make hormone therapy necessary if satisfactory results could not be obtained with medicinal products containing low-dose cyproterone or with other treatment options. when treating acne, hormone treatment should be weighed against systemic antibiotic treatment